You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Patient characteristics

From: A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy

Age ± stdev, y 69.7 ± 6.6
Range 55–82
PSA ± stdev, ng/mL 9 ± 5.3
Range 2.7–24.5
Gleason score 6 (%) 25
Gleason score 7 (%) 75
Primary GS 4 (%) 47
Cores involved ± stdev (#) 3.9 ± 2.4
Range 1–9
Cores involved ± stdev (%) 30 ± 19
Range 10–75
Clinical stage:
 cT1c 72
 cT2a 17
 cT2b 13
AUA score ± stdeva 9 ± 7
Range 0–20
SHIM score ± stdevb 14 ± 8.7
Range 0-26
Prostate volume ± stdev (cc) 40.1 ± 22.5
Range 13–108
  1. aAUA = American Urological Association Symptom Score
  2. bSHIM = Sexual Health Inventory for Men Score